bluebird bio
BLUE
#10271
Rank
NZ$88.56 M
Marketcap
NZ$9.04
Share price
0.00%
Change (1 day)
-75.11%
Change (1 year)

EPS for bluebird bio (BLUE)

EPS in 2025 (TTM): NZ-$40.88

According to bluebird bio 's latest financial reports the company's current EPS (TTM) is NZ-$45.15. In 2022 the company made an earnings per share (EPS) of NZ-$130.30 an increase over its 2021 EPS that were of NZ-$434.93.

EPS history for bluebird bio from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$40.88
2022NZ-$130.30-70.04%
2021NZ-$434.9320.1%
2020NZ-$362.14-30.47%
2019NZ-$520.8334.11%
2018NZ-$388.3539.3%
2017NZ-$278.798.5%
2016NZ-$256.9647.08%
2015NZ-$174.70169.66%
2014NZ-$64.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.60-107.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.81-104.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ-$0.69-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ-$0.95-97.90%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA